$PHIO
Phio Pharmaceuticals Corp. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Phio Pharmaceuticals Corp. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is PHIO down today? It is at $0.656 (-8.25%), and our scanner flagged it 4 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PHIO spikes, and full due diligence on PHIO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PHIO 4 times in the last 30 days. Create a free account to track $PHIO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how PHIO traded in the last session, Friday (last price and move above). Our scanner fired 2 unusual-volume and momentum alerts on PHIO on Friday, peaking at 16.7x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →Across every filing on file, supply equal to 46.7% of the tradeable float is in play - 46.7% more can still be issued.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
4,968,750 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $6.4M in size · Priced at $1.28/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Deming David H Director | Bought (open market) | +3K 0.03% of company | added 5.1% | 62K | $2K at $0.830 | Nov 13, 26 |
Deming David H Director | Bought (open market) | +9K 0.08% of company | added 18% | 59K | $7K at $0.810 | Nov 12, 26 |
Deming David H Director | Bought (open market) | +5K 0.04% of company | added 12% | 50K | $4K at $0.840 | Nov 11, 26 |
Deming David H Director | Bought (open market) | +7K 0.06% of company | added 18% | 45K | $6K at $0.840 | Nov 10, 26 |
Bitterman Robert J Officer | Bought (open market) | +25K 0.2% of company | added 3.3% | 790K | $21K at $0.820 | Nov 9, 26 |
Plott Ronald Todd Director | Bought (open market) | +18K 0.2% of company | added 44% | 60K | $15K at $0.830 | Nov 9, 26 |
Plott Ronald Todd Director | Bought (open market) | +5K 0.04% of company | added 14% | 42K | $5K at $1.04 | Sep 29, 26 |
Bitterman Robert J Officer | Acquired (grant/award) | +400K 3.3% of company | added 100% | 765K | n/a | Sep 28, 26 |
Carson Lisa Cabott Officer | Acquired (grant/award) | +108K 0.9% of company | added 100% | 189K | n/a | Sep 28, 26 |
Plott Ronald Todd Director | Acquired (grant/award) | +17K 0.1% of company | added 100% | 32K | n/a | Sep 28, 26 |
Plott Ronald Todd Director | Bought (open market) | +5K 0.04% of company | added 16% | 37K | $5K at $1.03 | Sep 28, 26 |
Bradford Patricia A Director | Bought (open market) | +7K 0.05% of company | added 11% | 64K | $7K at $1.01 | Sep 24, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how PHIO traded in the last session, Friday (last price and move above). Our scanner fired 2 unusual-volume and momentum alerts on PHIO on Friday, peaking at 16.7x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
PHIO last traded at $0.656, down 8.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The PHIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PHIO 4 times in the last 30 days.
PHIO (Phio Pharmaceuticals Corp. Common Stock) trades on XNAS, with a market cap of about $8M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PHIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PHIO discussion
Sign in to ask a question or join the discussion.